Acute hepatitis in a patient treated with saquinavir and ritonavir: Absence of cross-toxicity with indinavir

被引：2

作者：

Vandercam, B

Moreau, M

Horsmans, C

Gala, JL

机构：

[1] Clin Univ St Luc, Dept Internal Med, B-1200 Brussels, Belgium

[2] Clin Univ St Luc, Dept Gastroenterol, B-1200 Brussels, Belgium

[3] Belgian Armed Forces, Queen Astrid Mil Hosp, B-1120 Brussels, Belgium

来源：

INFECTION | 1998年 / 26卷 / 05期

关键词：

D O I：

10.1007/BF02962257

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

收藏

页码：313 / 313

页数：1

相关论文

共 4 条

[1] Protease inhibitors in patients with HIV disease - Clinically important pharmacokinetic considerations
Barry, M
Gibbons, S
Back, D
Mulcahy, F
[J]. CLINICAL PHARMACOKINETICS, 1997, 32 (03) : 194 - 209
[2] Severe hepatitis in three AIDS patients treated with indinavir
Brau, N
Leaf, HL
Wieczorek, RL
Margolis, DM
[J]. LANCET, 1997, 349 (9056) : 924 - 925
[3] Severe hepatitis in patients with AIDS and haemophilia B treated with indinavir
Matsuda, J
Gohchi, K
[J]. LANCET, 1997, 350 (9074) : 364 - 364
[4] Pharmacokinetic interactions between antiepileptic drugs - Clinical considerations
Riva, R
Albani, F
Contin, M
Baruzzi, A
[J]. CLINICAL PHARMACOKINETICS, 1996, 31 (06) : 470 - 493